Abstract:Gene therapy has long held promise to correct a variety of human diseases and defects. Discovery of the Clustered Regularly-Interspaced Short Palindromic Repeats (CRISPR), the mechanism of the CRISPR-based prokaryotic adaptive immune system (CRISPR-associated system, Cas), and its repurposing into a potent gene editing tool has revolutionized the field of molecular biology and generated excitement for new and improved gene therapies. Additionally, the simplicity and flexibility of the CRISPR/Cas9 site-specific nuclease system has led to its widespread use in many biological research areas including development of model cell lines, discovering mechanisms of disease, identifying disease targets, development of transgene animals and plants, and transcriptional modulation. In this review, we present the brief history and basic mechanisms of the CRISPR/Cas9 system and its predecessors (ZFNs and TALENs), lessons learned from past human gene therapy efforts, and recent modifications of CRISPR/Cas9 to provide functions beyond gene editing. We introduce several factors that influence CRISPR/Cas9 efficacy which must be addressed before effective in vivo human gene therapy can be realized. The focus then turns to the most difficult barrier to potential in vivo use of CRISPR/Cas9, delivery. We detail the various cargos and delivery vehicles reported for CRISPR/Cas9, including physical delivery methods (e.g. microinjection; electroporation), viral delivery methods (e.g. adeno-associated virus (AAV); full-sized adenovirus and lentivirus), and non-viral delivery methods (e.g. liposomes; polyplexes; gold particles), and discuss their relative merits. We also examine several technologies that, while not currently reported for CRISPR/Cas9 delivery, appear to have promise in this field. The therapeutic potential of CRISPR/Cas9 is vast and will only increase as the technology and its delivery improves.

Applications and Research Advances in the Delivery of CRISPR/Cas9 Systems for the Treatment of Inherited Diseases

Delivery of CRISPR/Cas9 for Therapeutic Genome Editing

Exploring the Potential and Challenges of CRISPR Delivery and Therapeutics for Genetic Disease Treatment

Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing

CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications

Development and application of CRISPR/Cas9 technologies in genomic editing.

CRISPR/Cas9 therapeutics: progress and prospects

Advances in Therapeutic Application of CRISPR-Cas9

Nano-vectors for CRISPR/Cas9-mediated genome editing

CRISPR/Cas9 Mechanism and Applications Progression

Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics

Delivery of CRISPR/Cas9 by novel strategies for gene therapy.

Delivery of CRISPR/Cas9 by Novel Strategies for Gene Therapy

The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy

Delivering CRISPR: a review of the challenges and approaches

[Advances of Cas9/sgRNA delivery system for gene editing].

Delivering the CRISPR/Cas9 system for engineering gene therapies: Recent cargo and delivery approaches for clinical translation

The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases

Non-viral and Viral Delivery Systems for CRISPR-Cas9 Technology in the Biomedical Field

Cationic Polymeric Nanoformulation: Recent Advances in Material Design for CRISPR/Cas9 Gene Therapy

Precision in Action: The Role of Clustered Regularly Interspaced Short Palindromic Repeats/Cas in Gene Therapies